Usefulness and prognostic value of diagnostic tests in patients with possible chronic inflammatory demyelinating polyradiculoneuropathy.
chronic inflammatory demyelinating polyradiculoneuropathy
diagnostic tests
magnetic resonance imaging
nerve biopsy
prognostic factors
somatosensory evoked potentials
supportive criteria
Journal
Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
23
05
2022
received:
11
06
2021
accepted:
28
05
2022
pubmed:
7
6
2022
medline:
24
8
2022
entrez:
6
6
2022
Statut:
ppublish
Résumé
Recent guidelines define chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and possible CIDP. The aims of our study were to evaluate the value of diagnostic tests to support the diagnosis of CIDP in patients with possible CIDP and to identify prognostic factors of therapeutic success. We conducted an observational retrospective two-center study between 2014 and 2019. We selected patients with a clinical presentation suggesting CIDP, but whose electrodiagnostic (EDX) test results did not meet the EFNS/PNS 2021 criteria. We analyzed epidemiologic and clinical features, axonal loss on EDX, cerebrospinal fluid (CSF), somatosensory evoked potentials (SSEPs), plexus magnetic resonance imaging (MRI), nerve biopsy, and therapeutic response. We selected 75 patients, among whom 30 (40%) responded to treatment. The positivity rates of CSF analysis, MRI and SSEPs were not influenced by the clinical presentation or by the delay between symptom onset and medical assessment. A high protein level in CSF, female gender, and a relapsing-remitting course predicted the therapeutic response. It is important to properly diagnose suspected CIDP not meeting EFNS/PNS 2021 EDX criteria by using supportive criteria. Specific epidemiological factors and a raised CSF protein level predict a response to treatment. Further prospective studies are needed to improve diagnosis and the prognostic value of diagnostic tests in CIDP.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
304-311Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Eldar AH, Chapman J. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification. Autoimmun Rev. 2014;13(4-5):525-530.
Oaklander AL, Lunn MP, Hughes RA, van Schaik I, Frost C, Chalk CH. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database of Systematic Reviews. 2017;1. doi:10.1002/14651858.CD010369.pub2
Van den Bergh PYK, Doorn PA, Hadden RDM, et al. European academy of neurology/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol. 2021;28(11):3556-3583.
Viala K, Maisonobe T, Stojkovic T, et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System. 2010;15(1):50-56.
Koutlidis RM, Ayrignac X, Pradat P-F, et al. Segmental somatosensory-evoked potentials as a diagnostic tool in chronic inflammatory demyelinating polyneuropathies, and other sensory neuropathies. Neurophysiologie Clinique/Clinical Neurophysiology. 2014;44(3):26780-26280.
Salhi H, Corcia P, Remer S, Praline J. Somatosensory evoked potentials in chronic inflammatory demyelinating Polyradiculoneuropathy. Journal of Clinical Neurophysiology. 2014;31(3):2415-2245.
Devic P, Petiot P, Mauguiere F. Diagnostic utility of somatosensory evoked potentials in chronic polyradiculopathy without electrodiagnostic signs of peripheral demyelination: SSEPs in atypical CIDP. Muscle Nerve. 2016;53(1):7883-7883.
Bosboom WMJ. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain. 2001;124(12):242738.
Jomier F, Bousson V, Viala K, et al. Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2020;27(1):1817-1187.
Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997;48(2):321-328.
Maisonobe T, Chassande B, Verin M, Jouni M, Leger JM, Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. Journal of Neurology, Neurosurgery & Psychiatry. 1996;61(1):36-42.
Camdessanche J-P, Jousserand G, Ferraud K, et al. The pattern and diagnostic criteria of sensory neuronopathy: a case-control study. Brain. 2009;132(7):172333.
Ruts L, Drenthen J, Jacobs BC, van Doorn PA, Dutch GBS study group. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010;74(21):1680-1686.
Liberatore G, Manganelli F, Cocito D, et al. Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database. J Peripher Nerv Syst. 2020;25(2):152-161.
Madonick MJ, Margolis J. Protein content of spinal fluid in diabetes mellitus: report on one hundred cases. AMA Arch Neurol Psychiatry. 1952;68:641-644.
Kobessho H, Oishi K, Hamaguchi H, Kanda F. Elevation of cerebrospinal fluid protein in patients with diabetes mellitus is associated with duration of diabetes. Eur Neurol. 2008;60(3):132-136.
Kuwabara S, Nakajima M, Matsuda S, Hattori T. Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy. Neurology. 1997;48(4):874-877.
Duggins AJ, McLeod JG, Pollard JD, et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain. 1999;122(7):1383-1390.
Goedee HS, van der Pol WL, Hendrikse J, van den Berg LH. Nerve ultrasound and magnetic resonance imaging in the diagnosis of neuropathy. Current Opinion in Neurology. 2018;31(5):526-533.
Shibuya K, Sugiyama A, Ito S, et al. Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathy: MR Neurography in CIDP. Ann Neurol. 2015;77(2):333-337.
Lozeron P, Lacour M-C, Vandendries C, et al. Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies. Journal of the Neurological Sciences. 2016;360:1705-1175.
Tracy JA, Dyck PJ, Klein CJ, Engelstad JK, Meyer JE, Dyck PJB. Onion-bulb patterns predict acquired or inherited demyelinating polyneuropathy. Muscle Nerve. 2019 Jun;59(6):665-670.
Hahn AF, Hartung HP, Dyck PJ. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy. 4th ed. Elsevier; 2005:2221-2254.
Svahn J, Petiot P, Antoine JC, et al. Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features. J Neurol Neurosurg Psychiatry. 2018;89(5):499-505.
Draak THP, Gorson KC, Vanhoutte EK, et al. Correlation of the patient's reported outcome inflammatory-RODS with an objective metric in immune-mediated neuropathies. European Journal of Neurology. 2016;23(7):1248-1253.
Fargeot G, Viala K, Theaudin M, et al. Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination. Eur J Neurol. 2019;26(4):6318-6638.
Oudeman J, Eftimov F, Strijkers GJ, et al. Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies. Neurology. 2020;94(1):e6274.
Tan C-Y, Arumugam T, Razali SNO, Yahya MA, Goh KJ, Shahrizaila N. Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy. Journal of Clinical Neuroscience. 2018;57:198-201.
Goedee HS, Herraets IJT, Visser LH, et al. Nerve ultrasound can identify treatment-responsive chronic neuropathies without electrodiagnostic features of demyelination. Muscle Nerve. 2019;60(4):415-419.
Bouchard C, Lacroix C, Plante V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;52(3):498, 503-498.
Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurological Science. 2000;21(1):31-37.
Viala K. Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies. International Journal of Neuroscience. 2016;126(9):77785-77785.
Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammatory demyelinating Polyradiculoneuropathy. Arch Neurol. 1989;46(8):878-884.
Boukhris S, Magy L, Kabore R, et al. Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP) - diagnosis confirmed by nerve biopsy. Neurophysiologie Clinique/Clinical Neurophysiology. 2004;34(2):719-779.
Vallat J-M, Tabaraud F, Magy L, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve. 2003;27(4):47885.
Lucke IM, Adrichem ME, Wieske L, et al. Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy. Journal of the Neurological Sciences. 2019;397:1415-1145.
Tackenberg B, Lunemann JD, Steinbrecher A, et al. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology. 2007;68(19):1622-1629.
Al-Zuhairy A, Sindrup SH, Andersen H, et al. A population-based study of long-term outcome in treated chronic inflammatory demyelinating polyneuropathy. Muscle Nerve$. 2020;61(3):316-324.
Rabin M, Mutlu G, Stojkovic T, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal. Journal of Neurology, Neurosurgery & Psychiatry. 2014;85(8):9016-9906.
Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. Journal of Neurology. 2002;249(5):569-575.
Laughlin RS, Dyck PJ, Melton LJ, Leibson C, Ransom J, Dyck PJB. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology. 2009;73(1):39-45.
Rajabally YA, Afzal S, Ghasemi M. Minimal important differences and self-identifying treatment response in chronic inflammatory demyelinating polyneuropathy. Muscle & Nerve. Juill. 2021;64(1):37-42.